Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Review"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Colafigli%2C+Gioia%22&type=Person&filter%5B%5D=topic_facet%3A%22Review%22
/vufind/Search/Results?lookfor=%22Colafigli%2C+Gioia%22&type=Person&filter%5B%5D=topic_facet%3A%22Review%22
Search /vufind/Search2/Results?lookfor=%22Colafigli%2C+Gioia%22&type=Person&filter%5B%5D=topic_facet%3A%22Review%22
PubPharm (15)
1
Future Management of Chronic Myeloid Leukemia : From Dose Optimization to New Agents
enthalten in:
Current cancer drug targets
| 2022
von
Breccia, M.
|
Scalzulli, E.
|
Pepe, S.
| +2
Wird geladen...
2
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients
enthalten in:
Expert review of hematology
| 2022
von
Breccia, M.
|
Scalzulli, E.
|
Pepe, S.
| +4
Wird geladen...
3
Asciminib : an investigational agent for the treatment of chronic myeloid leukemia
enthalten in:
Expert opinion on investigational drugs
| 2021
von
Breccia, M.
|
Colafigli, G.
|
Scalzulli, E.
| +1
Wird geladen...
4
Measuring prognosis in chronic myeloid leukemia : what's new?
enthalten in:
Expert review of hematology
| 2021
von
Breccia, M.
|
Efficace, F.
|
Scalzulli, E.
| +4
Wird geladen...
5
Therapeutic strategies in low and high-risk MDS : What does the future have to offer?
enthalten in:
Blood reviews
| 2021
von
Scalzulli, E.
|
Pepe, S.
|
Colafigli, G.
| +1
Wird geladen...
6
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia : Is it time to introduce it in the clinical practice?
enthalten in:
Critical reviews in oncology/hematology
| 2021
von
Colafigli, G.
|
Scalzulli, E.
|
Di Prima, A.
| +6
Wird geladen...
7
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia : a critical review of the current practice
enthalten in:
Expert review of hematology
| 2020
von
Breccia, M.
|
Efficace, F.
|
Colafigli, G.
| +4
Wird geladen...
8
The advantages and risks of ruxolitinib for the treatment of polycythemia vera
enthalten in:
Expert review of hematology
| 2020
von
Colafigli, G.
|
Scalzulli, E.
|
Pepe, S.
| +5
Wird geladen...
9
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia
enthalten in:
Therapeutic advances in hematology
| 2019
von
Molica, M.
|
Scalzulli, E.
|
Colafigli, G.
| +2
Wird geladen...
10
Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia : safety and efficacy
enthalten in:
Expert review of hematology
| 2018
von
Massaro, F.
|
Colafigli, G.
|
Molica, M.
| +1
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Review
Medienart
15
Aufsätze
15
E-Artikel
15
E-Ressourcen
Zeitschriftentitel
6
Expert review of hematology
2
Critical reviews in oncology/hematology
2
Leukemia research
1
Blood reviews
1
Current cancer drug targets
1
Expert opinion on drug safety
1
Expert opinion on investigational drugs
1
Therapeutic advances in hematology
Alle anzeigen ...
weniger ...
Thema
Review
14
Journal Article
9
Protein Kinase Inhibitors
8
Chronic myeloid leukemia
6
EC 2.7.10.2
5
Fusion Proteins, bcr-abl
4
tyrosine kinase inhibitors
3
Antineoplastic Agents
3
Prognosis
3
safety
3
treatment-free remission
2
BCR-ABL1 fusion protein, human
2
Pyrazoles
2
Pyrimidines
2
asciminib
2
deep molecular response
2
monitoring
1
25X51I8RD4
1
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluo...
1
82S8X8XX8H
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
7
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
15
Englisch
Haven't found what you're looking for?
Wird geladen...